OTCMKTS:ANTB

(ANTB) (ANTB) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.81
$0.83
50-Day Range
N/A
52-Week Range
$0.75
$1.25
Volume
2,100 shs
Average Volume
8,783 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (ANTB)

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

ANTB Stock News Headlines

These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Aerodrom Nikola Tesla ad AERO
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Remarkable Roman ruins still standing
Beautiful Roman ruins everyone should see
Staggering Roman ruins still standing
See More Headlines
Receive ANTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTB) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Internet Software & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANTB
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Nevan Charles Elam
    President, Chief Executive Officer, CFO & Director
  • Michael Deperro
    Head-Operations
  • Sankaram Mantripragada
    Chief Scientific Officer
  • Erin O’Boyle
    Head-Clinical Operations
  • Davelyn Hood
    Director-Scientific & Patient Affairs

ANTB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ANTB) own?
This page (OTCMKTS:ANTB) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners